SPC375
Ponesimod (IUPAC nafn: (R)-5-[3-klóró-4-(2,3-díhýdroxý-própoxý)-bens[Z]ýliden]-2-([Z]-própýlimínó)-3-ó-tólýl -þíasólidín-4-ón) og lyfjafræðilega viðeigandi sölt þar af
Status:
UmsóknApplication date:
11.5.2022Application published:
15.6.2022
Max expiry date:
20.5.2036Medicine name:
PONVORYMedicine for children:
No
Timeline
Today
11.5.2022Application
15.6.2022Publication
20.5.2036Expires
Marketing license
IS authorization number:
EU/1/21/1550/001; EU/1/21/1550/002Date:
9.6.2021
Foreign authorization number:
EU/1/21/1550Date:
19.5.2021
Owner
Name:
Laboratoires Juvise PharmaceuticalsAddress:
149, Boulevard Bataille de Stalingrad,, Villeurbanne i
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3256125